1 1

Omni Peptides

KPV

Dhs. 300.00 AED
Dhs. 300.00 AED
Sale Sold out
CHOOSE YOUR FORMAT

Size
Lyophilised & sealed vials
Independent COA · ≥99% purity
Cold-chain dispatch · same day Dubai
Discreet · unbranded outer packaging

Reduces inflammation, aids wound healing and GI repair

KPV is a synthetic tripeptide corresponding to the C-terminal sequence (residues 11-13) of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide with immunomodulatory properties. This research compound has garnered considerable scientific interest for its potent anti-inflammatory and tissue-protective effects in preclinical models. Preliminary studies suggest that KPV may attenuate inflammatory signaling pathways, reduce cytokine production, and support epithelial barrier function. Researchers utilize this peptide in laboratory settings to investigate mechanisms of inflammation resolution, particularly in models of gastrointestinal, dermal, and mucosal injury. As a research-grade compound, KPV is intended exclusively for in vitro and animal studies. Scientists value its potential to elucidate non-melanocortin receptor-mediated anti-inflammatory pathways.

Molecular Formula
C₁₆H₃₀N₄O₄
Molecular Weight
342.43 g/mol
Sequence
Lys-Pro-Val

Research Applications

01 Gastrointestinal Health and Mucosal Repair
Preclinical investigations demonstrate that KPV effectively reduces inflammation in models of inflammatory bowel disease (IBD), colitis, and oral mucositis. It promotes mucosal healing, attenuates pro-inflammatory cytokine expression, and supports gut barrier integrity via PepT1-mediated uptake.
02 Dermal and Wound Healing
KPV accelerates wound closure and re-epithelialization in cutaneous and corneal injury models. Studies highlight its role in reducing scar formation, enhancing collagen organization, and promoting tissue regeneration in chronic ulcers and inflammatory skin conditions.
03 Anti-Inflammatory and Immunomodulatory Effects
KPV potently inhibits NF-κB and MAPK signaling pathways, decreasing production of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8. It shifts cellular responses toward resolution of inflammation without melanogenic activity.
04 Antimicrobial Properties
Research indicates KPV exhibits direct antimicrobial effects against pathogens like Staphylococcus aureus and Candida albicans, complementing its anti-inflammatory actions in infected wound models.
05 Broader Tissue Protection
Preliminary data suggest potential benefits in reducing fibrosis, oxidative stress, and immune-mediated damage in various organ systems, including ocular and bronchial tissues.

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.

Molecular Formula
C₁₆H₃₀N₄O₄
Molecular Weight
342.43 g/mol
Sequence
Lys-Pro-Val

— About this compound

KPV is a synthetic anti-inflammatory tripeptide.

KPV is a synthetic tripeptide corresponding to the C-terminal sequence (residues 11-13) of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide with immunomodulatory properties. This research compound has garnered considerable scientific interest for its potent anti-inflammatory and tissue-protective effects in preclinical models. Preliminary studies suggest that KPV may attenuate inflammatory signaling pathways, reduce cytokine production, and support epithelial barrier function. Researchers utilize this peptide in laboratory settings to investigate mechanisms of inflammation resolution, particularly in models of gastrointestinal, dermal, and mucosal injury. As a research-grade compound, KPV is intended exclusively for in vitro and animal studies. Scientists value its potential to elucidate non-melanocortin receptor-mediated anti-inflammatory pathways.

VIAL ANATOMY
LYOPHILISED VIAL
Flip-off cap
Tamper-evident seal
Rubber stopper
Bacteriostatic-water compatible
Batch-labelled body
Lot & expiry printed
USP Type I glass
Borosilicate, sealed
KPV vial
KPV
10mg
DUBAI PEPTIDES
RESEARCH USE ONLY
BLACK RESEARCH SERIES

Research Applications

Where researchers apply it.

01 Gastrointestinal Health and Mucosal Repair
Preclinical investigations demonstrate that KPV effectively reduces inflammation in models of inflammatory bowel disease (IBD), colitis, and oral mucositis. It promotes mucosal healing, attenuates pro-inflammatory cytokine expression, and supports gut barrier integrity via PepT1-mediated uptake.
02 Dermal and Wound Healing
KPV accelerates wound closure and re-epithelialization in cutaneous and corneal injury models. Studies highlight its role in reducing scar formation, enhancing collagen organization, and promoting tissue regeneration in chronic ulcers and inflammatory skin conditions.
03 Anti-Inflammatory and Immunomodulatory Effects
KPV potently inhibits NF-κB and MAPK signaling pathways, decreasing production of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8. It shifts cellular responses toward resolution of inflammation without melanogenic activity.
04 Antimicrobial Properties
Research indicates KPV exhibits direct antimicrobial effects against pathogens like Staphylococcus aureus and Candida albicans, complementing its anti-inflammatory actions in infected wound models.
05 Broader Tissue Protection
Preliminary data suggest potential benefits in reducing fibrosis, oxidative stress, and immune-mediated damage in various organ systems, including ocular and bronchial tissues.

— Verified & Documented

Every vial is backed by a Certificate of Analysis.

Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.

Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.

>99%
HPLC Purity
MS
Identity Confirmed
Certificate of Analysis
KPV · BATCH KP30-0115 · QC RELEASE
PASS
IdentityConfirmed
Mass37.52 mg
Purity99.80%
AppearanceWhite Lyophilised
LabJanoshik Analytical (Independant)
Date23/01/26

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.